Skip to main content
. 2017 Jun 29;38(2):703–714. doi: 10.3892/or.2017.5767

Figure 8.

Figure 8.

Galangin impedes human laryngeal carcinoma TU212 and HEP-2 cell proliferation via suppressing mTOR. (A) Western blot analysis was carried out to evaluate TSC1, p-mTOR and mTOR expression in TU212 and HEP-2 cells. TSC1 and p-mTOR protein levels in (B) TU212 and (C) HEP-2 cells were quantified after western blot assays. (D) Immunofluorescence assays were carried out to determine TSC1 positive cells in TU212 and HEP-2 cells. The quantification of TSC1 positive cells in (E) TU212 and (F) HEP-2 cells is shown. The analysis was conducted in triplicate, and the results are the mean ± SEM of three independent experiments. ***P<0.001 (compared to the control/Con).